Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire
Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected.<sup>1</sup> Of all SSc manifestations, GI disease has the greatest impact on quality of life.<sup>2</sup>
Authors
- Sam Shan (ORCID: https://orcid.org/0000-0003-3377-5972)
- Linda Ross (ORCID: https://orcid.org/0000-0003-3978-5952)
- Kate M. Seaton
Institutions
- St Vincent's Hospital Melbourne (AU)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.3899/jrheum.2025-1226
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Arthritis Australia